ARVN

ARVINAS, INC.

Healthcare · Biotechnology

$277.31 sample

+3.55 (+1.30%) 1D

Market cap

$1.04T

Price as of

2026-10-04

Latest filing

8-K · 2026-09-11

Alerts

8

Price$277.31 +4.59% 3M daily closessample

280.85258.69

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 24INSInsider buy: Chief Executive Officer
Sep 18INSInsider buy: EVP, Operations
Sep 11SECDEF 14A filed
Sep 03INSInsider sell: Chief Executive Officer
Aug 31INSInsider sell: Director
Aug 20INSInsider sell: Chief Executive Officer
Aug 14SEC8-K filed: material event
Aug 07INSInsider buy: EVP, Operations

Sign up to see the real ARVN record →

Company facts

SEC EDGAR registration

Name: ARVINAS, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -18sample, -100 to +100
Reporting currency: USD

Who is positioning in ARVN

sample

Insiders: 8 insider transactions over 90 days, net selling, $275.9M
Congress: 2 members traded over 90 days
Institutions · 13F: 29 funds hold $12.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$43.2B +22.4% y/y

Q4 2024Q3 2026

Inventory$26.1B +20.4% y/y

Q4 2024Q3 2026

Accounts receivable$18.2B +4.6% y/y

Q4 2024Q3 2026

Total debt$51.7B +13.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $294.8B +13.3% 3M
Sample peer B: $924.1B +8.7% 3M
Sample peer C: $235.5B +8.6% 3M
Sample peer D: $336.4B +2.9% 3M
Sample peer E: $428.6B +15.1% 3M